About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
CancerGRACE's ASCO 2019 Update on Stage IV NSCLC: New Targets - RET
By
GRACE
FEATURING
Jack West
,
Benjamin Levy
,
Charu Aggarwal
By
GRACE
FEATURING
Jack West
,
Benjamin Levy
,
Charu Aggarwal
140 views
September 24, 2019
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
18:47
Total Health
Updates in the Management of NSCLC: Systemic Therapy Year in Review
Feat.
W. Iams
17:34
ecancer
Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…
Feat.
L. Raez
07:38
GRACE
How Does PD-L1 Score Affect Treatment Options for NSCLC
Feat.
S. Patel,
T. Leal,
P. Iyengar,
A. Desai,
C. Kim,
J. Rotow
20:28
OncoAlert
mNSCLC Updates: 1L EGFRm, 2/3L EGFRm & Anti-Trop2 ADC
Feat.
C. Aggarwal
10:34
GRACE
ASCO® 2023 Insights: "CheckMate 9LA 4-Year Follow-Up - Chemo + …
Feat.
J. West,
C. Lovly,
A. Addeo
07:13
Insights from 2023 WCLC
WCLC 2023 Insights: "5-Year Survival of Pembro + Chemo for mNSC…
Feat.
S. Gadgeel
13:01
Nebraska Oncology Society
ASCO 2022 on Immunotherapy Updates in Advanced NSCLC
Feat.
J. Brahmer
12:26
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024
2024 Neuro-Oncology Update: NSCLC and Brain Mets
Feat.
T. McGranahan
06:53
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "RAMOSE Trial - Osimertinib+/-Ramucirumab i…
Feat.
X. Le
18:14
Janakiraman Subramanian
Understanding KRAS G12C Positive Lung Cancer
10:29
NYU Langone
FDA Approval of Adagrasib in KRAS G12Cm NSCLC
Feat.
J. Sabari
12:16
ecancer
ASCO® 2023 Summary: "Analysis of Key Studies in Lung Cancer - A…
Feat.
L. Raez
33:37
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course
Fred Hutchinson Cancer Center Review of Metastatic NSCLC
Feat.
C. Baik
04:14
ecancer
ASCO® 2023 Insights: "Phase 3 LUNAR Study - Tumor Treating Fiel…
Feat.
T. Leal
21:35
Total Health
Management of Advanced NSCLC: IO, Targeted Therapy, and Beyond
Feat.
T. Patil
14:26
Memorial Sloan Kettering Cancer Center
Radiation for Unresectable NSCLC: Where Are We Now and Where Are We …
Feat.
D. Gomez
14:33
ILCC 2022 Conference Coverage
1L Single Agent Immunotherapy for mNSCLC
Feat.
A. Chiang
04:29
GRACE
Dual Immune Checkpoint Blockade With or Without Chemotherapy for mNS…
Feat.
C. Kim
14:11
Lorenzo Belluomini
Selpercatinib in RET Fusion-Positive mNSCLC: Achievements and Gray A…
21:04
2022 West Oncology Conference
Metastatic NSCLC: Approaches and Updates
Feat.
J. Porter
